Guarantor Information (Details) - USD ($) $ in Millions	3 Months Ended			12 Months Ended
	Mar. 30, 2019	Mar. 31, 2018		Dec. 29, 2018	Dec. 30, 2017
Net sales	$ 487.3	$ 542.6
Other revenue	0.0	0.0
Cost of Products Sold	161.2	179.0
Gross margin	326.1	363.6
Delivery, sales and administrative expense	262.7	289.2
Re-engineering and impairment charges	4.3	7.6	[1]
(Loss) gain on disposal of assets	(0.9)	2.2
Operating income	58.2	69.0
Interest income	0.6	0.7
Interest expense	10.2	11.1
Income from equity investments in subsidiaries	0.0	0.0
Other (income) expense	(3.3)	0.2
Income before income taxes	51.9	58.4
Provision (benefit) for income taxes	15.0	22.7
Net income	36.9	35.7
Comprehensive income	55.9	43.4
ASSETS
Cash and cash equivalents	146.8			$ 149.0
Accounts receivable, net	167.0			144.7
Inventories	269.0			257.7
Non-trade amounts receivable, net	51.8			49.9
Intercompany receivables	0.0			0.0
Prepaid expenses and other current assets	21.0			19.3
Total current assets	655.6			620.6
Deferred income tax benefits, net	226.7			217.0
Property, plant and equipment, net	277.9			276.0
Operating Lease, Right-of-Use Asset	82.0			0.0
Long-term receivables, net	17.6			18.7
Trademarks and tradenames, net	52.3			52.9
Goodwill	77.5			76.1
Investments in subsidiaries	0.0			0.0
Intercompany notes receivable	0.0			0.0
Other assets, net	49.2			47.5
Total assets	1,438.8			1,308.8
LIABILITIES AND SHAREHOLDERS' EQUITY
Accounts payable	81.5			129.2
Short-term borrowings and current portion of long-term debt and finance lease obligations	367.8			285.5
Intercompany payables	0.0			0.0
Accrued liabilities	347.6			344.4
Total current liabilities	796.9			759.1
Long-term debt and finance lease obligations	603.0			603.4
Intercompany notes payable	0.0			0.0
Operating Lease, Liability, Noncurrent	52.7			0.0
Other liabilities	170.2			181.5
Total shareholders' deficit	(184.0)	(108.4)		(235.2)	$ (119.4)
Total liabilities and shareholders' deficit	1,438.8			1,308.8
Operating Activities:
Net cash used in operating activities	(40.1)	(40.8)
Investing Activities:
Capital expenditures	(12.9)	(15.2)
Proceeds from disposal of property, plant and equipment	0.6	5.9
Net intercompany loans	0.0	0.0
Net cash used in investing activities	(12.3)	(9.3)
Financing Activities:
Dividend payments to shareholders	(33.9)	(35.4)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees	0.0	0.0
Proceeds from exercise of stock options	0.0	0.2
Repurchase of common stock	(0.7)	(1.0)
Repayment of finance lease obligations	(0.3)	(0.5)
Net change in short-term debt	84.1	97.2
Payments of Debt Issuance Costs	(1.3)	0.0
Net intercompany borrowings	0.0	0.0
Net cash provided by financing activities	47.9	60.5
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	3.1	4.1
Net change in cash, cash equivalents and restricted cash	(1.4)	14.5
Cash, cash equivalents and restricted cash at beginning of year	151.9	147.2		147.2
Cash, cash equivalents and restricted cash at end of period	150.5	161.7		151.9
Parent
Net sales	0.0	0.0
Other revenue	0.0	0.0
Cost of Products Sold	0.0	0.0
Gross margin	0.0	0.0
Delivery, sales and administrative expense	1.5	3.0
Re-engineering and impairment charges	0.0	0.0
(Loss) gain on disposal of assets	0.0	0.0
Operating income	(1.5)	(3.0)
Interest income	5.5	5.1
Interest expense	9.5	9.2
Income from equity investments in subsidiaries	40.8	40.8
Other (income) expense	(0.5)	(0.6)
Income before income taxes	35.8	34.3
Provision (benefit) for income taxes	(1.1)	(1.4)
Net income	36.9	35.7
Comprehensive income	55.9	43.4
ASSETS
Cash and cash equivalents	0.0			0.0
Accounts receivable, net	0.0			0.0
Inventories	0.0			0.0
Non-trade amounts receivable, net	0.0			0.0
Intercompany receivables	310.5			309.2
Prepaid expenses and other current assets	1.0			1.1
Total current assets	311.5			310.3
Deferred income tax benefits, net	41.7			41.7
Property, plant and equipment, net	0.0			0.0
Operating Lease, Right-of-Use Asset	0.0
Long-term receivables, net	0.0			0.0
Trademarks and tradenames, net	0.0			0.0
Goodwill	0.0			0.0
Investments in subsidiaries	1,371.9			1,305.3
Intercompany notes receivable	486.6			515.3
Other assets, net	1.1			0.3
Total assets	2,212.8			2,172.9
LIABILITIES AND SHAREHOLDERS' EQUITY
Accounts payable	0.1			0.0
Short-term borrowings and current portion of long-term debt and finance lease obligations	253.3			189.4
Intercompany payables	1,276.2			1,330.9
Accrued liabilities	265.6			278.6
Total current liabilities	1,795.2			1,798.9
Long-term debt and finance lease obligations	599.6			599.7
Intercompany notes payable	0.0			6.6
Operating Lease, Liability, Noncurrent	0.0
Other liabilities	2.0			2.9
Total shareholders' deficit	(184.0)			(235.2)
Total liabilities and shareholders' deficit	2,212.8			2,172.9
Operating Activities:
Net cash used in operating activities	3.8	(4.4)
Investing Activities:
Capital expenditures	0.0	0.0
Proceeds from disposal of property, plant and equipment	0.0	0.0
Net intercompany loans	22.2	(64.3)
Net cash used in investing activities	22.2	(64.3)
Financing Activities:
Dividend payments to shareholders	(33.9)	(35.4)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees	0.0	0.0
Proceeds from exercise of stock options	0.0	0.2
Repurchase of common stock	(0.7)	(1.0)
Repayment of finance lease obligations	0.0	0.0
Net change in short-term debt	64.6	87.0
Payments of Debt Issuance Costs	(1.3)
Net intercompany borrowings	(54.7)	17.9
Net cash provided by financing activities	(26.0)	68.7
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	0.0	0.0
Net change in cash, cash equivalents and restricted cash	0.0	0.0
Cash, cash equivalents and restricted cash at beginning of year	0.0	0.0		0.0
Cash, cash equivalents and restricted cash at end of period	$ 0.0	0.0		0.0
Guarantor
Equity Method Investment, Ownership Percentage	100.00%
Net sales	$ 0.0	0.0
Other revenue	19.9	21.7
Cost of Products Sold	9.6	10.0
Gross margin	10.3	11.7
Delivery, sales and administrative expense	18.9	22.3
Re-engineering and impairment charges	0.6	0.3
(Loss) gain on disposal of assets	0.0	0.0
Operating income	(9.2)	(10.9)
Interest income	0.7	0.5
Interest expense	13.2	15.5
Income from equity investments in subsidiaries	60.3	70.5
Other (income) expense	3.0	12.0
Income before income taxes	35.6	32.6
Provision (benefit) for income taxes	(3.4)	(6.3)
Net income	39.0	38.9
Comprehensive income	57.6	51.9
ASSETS
Cash and cash equivalents	0.3			0.3
Accounts receivable, net	0.0			0.0
Inventories	0.0			0.0
Non-trade amounts receivable, net	166.5			169.0
Intercompany receivables	1,358.4			1,430.1
Prepaid expenses and other current assets	5.3			3.7
Total current assets	1,530.5			1,603.1
Deferred income tax benefits, net	42.2			42.2
Property, plant and equipment, net	74.6			71.3
Operating Lease, Right-of-Use Asset	0.5
Long-term receivables, net	0.1			0.1
Trademarks and tradenames, net	0.0			0.0
Goodwill	2.9			2.9
Investments in subsidiaries	1,514.5			1,346.8
Intercompany notes receivable	97.7			95.4
Other assets, net	0.3			0.5
Total assets	3,263.3			3,162.3
LIABILITIES AND SHAREHOLDERS' EQUITY
Accounts payable	3.8			5.7
Short-term borrowings and current portion of long-term debt and finance lease obligations	0.0			0.0
Intercompany payables	428.5			436.3
Accrued liabilities	57.7			69.2
Total current liabilities	490.0			511.2
Long-term debt and finance lease obligations	0.0			0.0
Intercompany notes payable	1,424.7			1,366.7
Operating Lease, Liability, Noncurrent	0.3
Other liabilities	47.4			48.1
Total shareholders' deficit	1,300.9			1,236.3
Total liabilities and shareholders' deficit	3,263.3			3,162.3
Operating Activities:
Net cash used in operating activities	(115.4)	(42.9)
Investing Activities:
Capital expenditures	(7.5)	(5.5)
Proceeds from disposal of property, plant and equipment	0.0	0.0
Net intercompany loans	53.6	(5.5)
Net cash used in investing activities	46.1	(11.0)
Financing Activities:
Dividend payments to shareholders	0.0	0.0
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees	0.0	0.0
Proceeds from exercise of stock options	0.0	0.0
Repurchase of common stock	0.0	0.0
Repayment of finance lease obligations	0.0	0.0
Net change in short-term debt	0.0	0.0
Payments of Debt Issuance Costs	0.0
Net intercompany borrowings	69.3	54.1
Net cash provided by financing activities	69.3	54.1
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	0.0	0.0
Net change in cash, cash equivalents and restricted cash	0.0	0.2
Cash, cash equivalents and restricted cash at beginning of year	0.3	0.1		0.1
Cash, cash equivalents and restricted cash at end of period	0.3	0.3		0.3
Non-Guarantors
Net sales	488.3	542.8
Other revenue	9.5	10.1
Cost of Products Sold	182.0	198.7
Gross margin	315.8	354.2
Delivery, sales and administrative expense	242.3	266.2
Re-engineering and impairment charges	3.7	7.3
(Loss) gain on disposal of assets	(0.9)	2.2
Operating income	68.9	82.9
Interest income	10.1	10.8
Interest expense	3.2	2.1
Income from equity investments in subsidiaries	0.0	0.0
Other (income) expense	(5.8)	(11.2)
Income before income taxes	81.6	102.8
Provision (benefit) for income taxes	19.5	30.4
Net income	62.1	72.4
Comprehensive income	93.0	98.3
ASSETS
Cash and cash equivalents	146.5			148.7
Accounts receivable, net	167.0			144.7
Inventories	269.0			257.7
Non-trade amounts receivable, net	96.1			71.0
Intercompany receivables	230.2			230.5
Prepaid expenses and other current assets	41.5			48.2
Total current assets	950.3			900.8
Deferred income tax benefits, net	142.8			133.1
Property, plant and equipment, net	203.3			204.7
Operating Lease, Right-of-Use Asset	81.5
Long-term receivables, net	17.5			18.6
Trademarks and tradenames, net	52.3			52.9
Goodwill	74.6			73.2
Investments in subsidiaries	0.0			0.0
Intercompany notes receivable	1,117.7			1,069.4
Other assets, net	76.5			75.3
Total assets	2,716.5			2,528.0
LIABILITIES AND SHAREHOLDERS' EQUITY
Accounts payable	77.6			123.5
Short-term borrowings and current portion of long-term debt and finance lease obligations	114.5			96.1
Intercompany payables	194.4			202.6
Accrued liabilities	261.9			220.4
Total current liabilities	648.4			642.6
Long-term debt and finance lease obligations	3.4			3.7
Intercompany notes payable	277.3			306.8
Operating Lease, Liability, Noncurrent	52.4
Other liabilities	149.5			159.1
Total shareholders' deficit	1,585.5			1,415.8
Total liabilities and shareholders' deficit	2,716.5			2,528.0
Operating Activities:
Net cash used in operating activities	74.4	10.6
Investing Activities:
Capital expenditures	(5.4)	(9.7)
Proceeds from disposal of property, plant and equipment	0.6	5.9
Net intercompany loans	(64.3)	(56.7)
Net cash used in investing activities	(69.1)	(60.5)
Financing Activities:
Dividend payments to shareholders	0.0	0.0
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees	(2.7)	(1.2)
Proceeds from exercise of stock options	0.0	0.0
Repurchase of common stock	0.0	0.0
Repayment of finance lease obligations	(0.3)	(0.5)
Net change in short-term debt	19.5	10.2
Payments of Debt Issuance Costs	0.0
Net intercompany borrowings	(26.3)	51.6
Net cash provided by financing activities	(9.8)	60.1
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	3.1	4.1
Net change in cash, cash equivalents and restricted cash	(1.4)	14.3
Cash, cash equivalents and restricted cash at beginning of year	151.6	147.1		147.1
Cash, cash equivalents and restricted cash at end of period	150.2	161.4		151.6
Eliminations
Net sales	(1.0)	(0.2)
Other revenue	(29.4)	(31.8)
Cost of Products Sold	(30.4)	(29.7)
Gross margin	0.0	(2.3)
Delivery, sales and administrative expense	0.0	(2.3)
Re-engineering and impairment charges	0.0	0.0
(Loss) gain on disposal of assets	0.0	0.0
Operating income	0.0	0.0
Interest income	(15.7)	(15.7)
Interest expense	(15.7)	(15.7)
Income from equity investments in subsidiaries	(101.1)	(111.3)
Other (income) expense	0.0	0.0
Income before income taxes	(101.1)	(111.3)
Provision (benefit) for income taxes	0.0	0.0
Net income	(101.1)	(111.3)
Comprehensive income	(150.6)	(150.2)
ASSETS
Cash and cash equivalents	0.0			0.0
Accounts receivable, net	0.0			0.0
Inventories	0.0			0.0
Non-trade amounts receivable, net	(210.8)			(190.1)
Intercompany receivables	(1,899.1)			(1,969.8)
Prepaid expenses and other current assets	(26.8)			(33.7)
Total current assets	(2,136.7)			(2,193.6)
Deferred income tax benefits, net	0.0			0.0
Property, plant and equipment, net	0.0			0.0
Operating Lease, Right-of-Use Asset	0.0
Long-term receivables, net	0.0			0.0
Trademarks and tradenames, net	0.0			0.0
Goodwill	0.0			0.0
Investments in subsidiaries	(2,886.4)			(2,652.1)
Intercompany notes receivable	(1,702.0)			(1,680.1)
Other assets, net	(28.7)			(28.6)
Total assets	(6,753.8)			(6,554.4)
LIABILITIES AND SHAREHOLDERS' EQUITY
Accounts payable	0.0			0.0
Short-term borrowings and current portion of long-term debt and finance lease obligations	0.0			0.0
Intercompany payables	(1,899.1)			(1,969.8)
Accrued liabilities	(237.6)			(223.8)
Total current liabilities	(2,136.7)			(2,193.6)
Long-term debt and finance lease obligations	0.0			0.0
Intercompany notes payable	(1,702.0)			(1,680.1)
Operating Lease, Liability, Noncurrent	0.0
Other liabilities	(28.7)			(28.6)
Total shareholders' deficit	(2,886.4)			(2,652.1)
Total liabilities and shareholders' deficit	(6,753.8)			(6,554.4)
Operating Activities:
Net cash used in operating activities	(2.9)	(4.1)
Investing Activities:
Capital expenditures	0.0	0.0
Proceeds from disposal of property, plant and equipment	0.0	0.0
Net intercompany loans	(11.5)	126.5
Net cash used in investing activities	(11.5)	126.5
Financing Activities:
Dividend payments to shareholders	0.0	0.0
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees	2.7	1.2
Proceeds from exercise of stock options	0.0	0.0
Repurchase of common stock	0.0	0.0
Repayment of finance lease obligations	0.0	0.0
Net change in short-term debt	0.0	0.0
Payments of Debt Issuance Costs	0.0
Net intercompany borrowings	11.7	(123.6)
Net cash provided by financing activities	14.4	(122.4)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	0.0	0.0
Net change in cash, cash equivalents and restricted cash	0.0	0.0
Cash, cash equivalents and restricted cash at beginning of year	0.0	0.0		0.0
Cash, cash equivalents and restricted cash at end of period	$ 0.0	$ 0.0		$ 0.0

[1] (a) See Note 7 to the Consolidated Financial Statements for a discussion of re-engineering and impairment charges.